Therefore, future work should investigate whether the degreeof Hb decline is more severe in patients with anaemia in the first 24 h afterEVAR and whether they are likely to develop chronic anaemia following EVARtreatment. This evidence concerns the gene GSTM1 and anemia (phenotype).